ACUTE LEUKEMIA IN REMISSION
Clinical trials for ACUTE LEUKEMIA IN REMISSION explained in plain language.
Never miss a new study
Get alerted when new ACUTE LEUKEMIA IN REMISSION trials appear
Sign up with your email to follow new studies for ACUTE LEUKEMIA IN REMISSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a cancer drug shield young transplant patients from a deadly complication?
Disease control OngoingThis study tests whether adding the drug vorinostat to standard care can prevent graft-versus-host disease (GVHD) in children, adolescents, and young adults receiving a bone marrow or blood stem cell transplant for blood cancers. Researchers are first finding the best dose of vor…
Matched conditions: ACUTE LEUKEMIA IN REMISSION
Phase: PHASE1, PHASE2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC
-
Could a common Weight-Loss drug shield the brain? early trial launches
Knowledge-focused TerminatedThis pilot study tests whether liraglutide (Saxenda), a weight-loss drug, can raise levels of a brain-protective protein called BDNF in 30 people with multiple sclerosis, long-COVID, or leukemia who are overweight and have memory or concentration problems. Participants will injec…
Matched conditions: ACUTE LEUKEMIA IN REMISSION
Phase: EARLY_PHASE1 • Sponsor: University of Chicago • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC